Monday, May 10, 2021 3:38:20 PM
Zacks Equity Research
Mon, May 10, 2021, 12:15 PM
3 min read
https://finance.yahoo.com/news/tilray-inc-tlry-reports-q1-161504378.html
Tilray, Inc. (TLRY) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.49 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -90%. A quarter ago, it was expected that this company would post a loss of $0.14 per share when it actually produced a loss of $0.08, delivering a surprise of 42.86%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Tilray, Inc. Which belongs to the Zacks Medical - Drugs industry, posted revenues of $48.02 million for the quarter ended March 2021, missing the Zacks Consensus Estimate by 22.38%. This compares to year-ago revenues of $52.1 million. The company has topped consensus revenue estimates just once over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Tilray, Inc. Shares have added about 95.9% since the beginning of the year versus the S&P 500's gain of 12.7%.
What's Next for Tilray, Inc.
While Tilray, Inc. Has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Tilray, Inc. Was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.09 on $68.89 million in revenues for the coming quarter and -$0.36 on $296.19 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Drugs is currently in the bottom 20% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Recent TLRY News
- 10 Barrel Brewing Introduces Pub Cerveza: a New Twist on ‘Cheap Fun.’ Series • GlobeNewswire Inc. • 05/03/2024 11:07:37 AM
- Tilray Brands Launches XMG Zero, a New ‘Better for You’ Cannabis Beverage • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American Hefeweizen • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Breckenridge Brewery Introduces New West Coast Style IPA ‘Ridge Runner’ • GlobeNewswire Inc. • 04/29/2024 11:00:00 AM
- Tilray Brands Celebrates Big Wins at the Craft Brewer’s Conference and 2024 World Beer Cup, the Most Prestigious Beer Competition in the World • GlobeNewswire Inc. • 04/25/2024 08:33:50 PM
- Tilray Brands Celebrates Epic 420 Weekend With Over 20,000 Fans Across the U.S. • GlobeNewswire Inc. • 04/25/2024 12:00:00 PM
- Sweetwater Brewing Unveils Modern Rebrand • GlobeNewswire Inc. • 04/25/2024 11:00:00 AM
- Good Supply Cannabis Introduces New Signature ‘Bud Squad’ Products • GlobeNewswire Inc. • 04/24/2024 11:00:00 AM
- Montauk Brewing’s Project 4:20 IPA Returns to Support Surfrider Foundation • GlobeNewswire Inc. • 04/18/2024 12:00:00 PM
- Good Supply Cannabis Brand Celebrates Earth Day and Unveils Environmental Impact of “Green You Can Feel Good About” Campaign • GlobeNewswire Inc. • 04/18/2024 11:00:00 AM
- Tilray Brands Lights Up 420 With Music Festivals and Celebrations Across The Country • GlobeNewswire Inc. • 04/17/2024 11:00:00 AM
- 10 Barrel Brewing Adds 'Juicy Drama' to Its Award-Winning HopBurst Family • GlobeNewswire Inc. • 04/11/2024 12:30:00 PM
- Montauk Brewing Releases Its First Non-Alcoholic Brew: Montauk N.A. IPA • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results • GlobeNewswire Inc. • 04/09/2024 11:00:00 AM
- U.S. Futures Show Mixed Movement, Crude Oil Prices Inch Up • IH Market News • 04/09/2024 10:42:21 AM
- Tilray Brands Announces 420 Activations Across Canada and Unveils Celebratory Product Lineup • GlobeNewswire Inc. • 04/04/2024 11:00:00 AM
- UPDATE – Redhook Brewery Announces New “Big Juicy Ballard” IPA and Revives IPA Daze Festival at the Brewlab on 4/20 Weekend • GlobeNewswire Inc. • 04/03/2024 06:02:00 PM
- Redhook Brewery Announces New “Big Juicy Ballard” IPA and Revives IPA Daze Festival at the Brewlab on 4/20 Weekend • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Tilray Medical Announces New Scientific Publication on Age-Related Patterns of Medical Cannabis Use • GlobeNewswire Inc. • 04/03/2024 11:00:00 AM
- Sweetwater Brewing Unveils New 420 Variety Pack • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
- UPDATE – Breckenridge Brewery Partners With Denver Nuggets to Launch Championship Edition Mile High City Golden Ale • GlobeNewswire Inc. • 03/28/2024 04:50:58 PM
- SweetWater Brewing Launches Hammer Red Amber Ale to Support Georgia Aquarium • GlobeNewswire Inc. • 03/28/2024 12:30:00 PM
- Breckenridge Brewery Announces Special Denver Nuggets Championship Edition Mile High City Golden Ale • GlobeNewswire Inc. • 03/28/2024 12:00:00 PM
- Tilray Brands, Inc. to Announce Third Quarter 2024 Financial Results on April 9, 2024 • GlobeNewswire Inc. • 03/28/2024 11:00:00 AM
- 10 Barrel Brewing Unveils Newest Ready-to-Drink Canned Cocktails • GlobeNewswire Inc. • 03/26/2024 11:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM